More or Less is produced in partnership with the Open University. Presenter: Tim Harford Reporter: Lizzy McNeill Producer: ...

And fourth, focus on changing the environment, not just people. We must shift the focus to the systems and structures that ...

To improve access to care, many professional organizations have advocated for classifying obesity as a disease. However, the ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Women and older adults taking the anti-obesity drug semaglutide may be at higher risk for muscle loss, but higher protein ...

Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with ...

Racial disparities in childhood obesity have risen due to social determinants, food insecurity, and systemic barriers, ...

An oral melanocortin-4 receptor agonist conferred significant BMI reductions among adolescents and adults with hypothalamic obesity, according to a presenter. As Healio previously reported, ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

ENDO 2025 spotlights breakthrough research in PCOS, obesity, diabetes, and rare endocrine disorders and offers practical updates for daily clinical care. As the sun rises over San Francisco, ...

Adults with obesity were more likely to achieve a 10% or greater weight loss at 1 year if they continued using their ...